or Try an Advanced Search...

    Biopharmaceutical Products Stocks List

    Symbol Grade Name % Change
    TKNO F Alpha Teknova, Inc. -1.16
    BMY F Bristol-Myers Squibb Company -0.68
    MRVI F Maravai LifeSciences Holdings, Inc. -3.09
    PHAR D Pharming Group N.V. 0.04
    RPRX D Royalty Pharma plc -1.03
    RNA B Avidity Biosciences, Inc. -0.80
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Pharmaceutical Products Biology Drug Therapies Molecular Diagnostics Pharmaceutical Acid Acute Kidney Injury Angioedema Antibody Assay Development Services Atrial Fibrillation Biopharmaceutical Development Bioprocess Bioprocessing Bioproduction C1 Inhibitor Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical Products stocks.

    Symbol Grade Name Weight
    XPH D SPDR S&P Pharmaceuticals ETF 8.06
    MOON C Direxion Moonshot Innovators ETF 8.03
    IHE B iShares U.S. Pharmaceutical ETF 7.94
    PILL F Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 6.35
    FTXH B First Trust Nasdaq Pharmaceuticals ETF 5.9
    View all Biopharmaceutical Products ETFs...
    Compare ETFs
    Compare MOON to PILL Compare PILL to FTXH Compare XPH to IHE

        Biopharmaceutical Products Stocks Recent News

        Date Stock Title
        Jun 14 BMY EU to require additional cancer risk labeling on CAR T therapies
        Jun 14 RNA Avidity Biosciences: Muscular Dystrophy Breakthrough Propels To A 'Buy' Upgrade
        Jun 14 BMY Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
        Jun 14 RNA Avidity Biosciences to Participate in Upcoming Investor Conference
        Jun 14 RNA Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
        Jun 14 RNA Avidity Biosciences raises $400M via stock offering
        Jun 14 RNA Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
        Jun 13 BMY Bristol Myers gets FDA approval for Autyro for NTRK-positive cancers
        Jun 13 BMY U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
        Jun 13 BMY Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least
        Jun 13 RNA Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
        Jun 12 RNA Avidity Biosciences announces proposed offering of common stock
        Jun 12 RNA The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A Record
        Jun 12 RNA Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock
        Jun 12 RNA Avidity gains on early Phase 1/2 data for muscle disorder therapy
        Jun 12 RNA Avidity drug for muscular dystrophy shows promise; Syntis takes new approach to weight loss
        Jun 12 RNA Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE™ Trial Demonstrating Greater Than 50 Percent Reduction in DUX4 Regulated Genes and Trends of Functional Improvement in People Living with Facioscapulohumeral Muscular Dystrophy
        Jun 12 MRVI Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc
        Jun 12 MRVI RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One
        Jun 11 BMY Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Pharmaceutical Products Biology Drug Therapies Molecular Diagnostics Pharmaceutical Acid Acute Kidney Injury Angioedema Antibody Assay Development Services Atrial Fibrillation Biopharmaceutical Development Bioprocess Bioprocessing Bioproduction C1 Inhibitor Cancer
        Biopharmaceutical Products

        Biopharmaceutical products are drugs or therapies that are produced using biotechnology. These products are created by manipulating living organisms or their components to make medicines that can be used to treat or prevent diseases. Examples of biopharmaceutical products include monoclonal antibodies, recombinant proteins, gene therapies, and vaccines.

        Browse All Tags